SPL Infusion commences commercial production of new IV fluid Infusion plant
The facility has been designed with a dual focus on efficiency and sustainability
The facility has been designed with a dual focus on efficiency and sustainability
With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
Changhua site meets international regulatory standards for global medical applications
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Subscribe To Our Newsletter & Stay Updated